![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
ACC Inhibitor Demonstrates Potent Antifibrotic Activity In Vitro and In Vivo
|
|
|
Reported by Jules Levin
EASL 2018 April 11-15 Paris France
Jamie Bates,1 Sarani Ghoshal,2 Lan Wei,2 David Hollenback,1 Kathy Liu,1 Saritha Kusam,1 Maisoun Sulfab,1 Henry Liu,1 Robert Brockett,1* David Newstrom,1 Igor Mikaelian,1* Ting Wang,1 Geraldine Harriman,3 William F. Westlin,3 Jennifer Rocnik,3 H. James Harwood,3 Rosana Kapeller,3* Bryan C. Fuchs,2 Adrian S. Ray,1 David G. Breckenridge1
1Gilead Sciences, Inc., Foster City, California, USA; 2Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA; 3Nimbus Therapeutics, Cambridge, Massachusetts *Formerly employed.
![EASL1](../images%20/051718/051718-1/EASL1.gif)
![EASL2](../images%20/051718/051718-1/EASL2.gif)
![EASL3](../images%20/051718/051718-1/EASL3.gif)
![EASL4](../images%20/051718/051718-1/EASL4.gif)
![EASL5](../images%20/051718/051718-1/EASL5.gif)
![EASL6](../images%20/051718/051718-1/EASL6.gif)
References
1. Abu-Elheiga L, et al. Proc Natl Acad Sci USA 2005;102:12011-6; 2. Mao J, et al. Proc Natl Acad Sci USA 2006;103:8552-7; 3. Harriman G, et al. Proc Natl Acad Sci USA 2016;113:E1796-805; 4. Lawitz EJ, et al. EASL 2017, abstr LBO-002; 5. Loomba R, et al. AASLD 2017, abstr LB-9.
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|